New Metabolic Biomarkers Open Door to Earlier Diagnosis, More Precise and Individualized Treatment of Children at Risk for Autism
NeuroPointDX presents further data from the Children’s Autism Metabolome Project at INSAR 2019 MADISON, WI (May 6, 2019): Continued analysis of samples from the Children’s Autism Metabolome Project (CAMP), the most comprehensive clinical study of metabolism in children who has autism spectrum disorder (ASD) conducted to date,...